Evogene Ltd. (EVGN)
TASE
Closed
Aug 24, 2026
Day's Range
171.5052 wk Range
116.00Overview - EVGN - Evogene Ltd.
Key Statistics
Valuation
Enterprise Value
2.72B
P/E (Trailing)
‪0.28‬
P/E (Forward)
‪-0.44‬
PEG Ratio
‪0.0050‬
Price / Sales (TTM)
‪14.82‬
Price / Book
‪211.46‬
EV / EBITDA
‪-1.31‬
Profitability
Gross Margin
‪61.07%‬
Profit Margin
‪-6.25%‬
Operating Margin
‪-952.09%‬
Return on Assets
‪-32.89%‬
Return on Equity
‪-171.75%‬
Ownership
Shares Outstanding
10.41M
Float
8.51M
Held by Insiders
‪27.85%‬
Held by Institutions
‪6.36%‬
Price stats
Beta
‪0.68‬
50-Day Avg
‪161.21‬
200-Day Avg
‪254.27‬
Dividends
Payout Ratio
‪0.00%‬
Peers - EVGN - Evogene Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TASE.
- EVGNTASEEvogene Ltd.2.73BMarket Cap-152.85%52-week change0.29P/E (Trailing)‪-6.25%‬Profit Margin
- AURATASEAura Investments Ltd.450.88BMarket Cap-41.71%52-week change17.71P/E (Trailing)‪12.50%‬Profit Margin
- ATRYTASEAtreyu Capital Markets Ltd.90.59BMarket Cap-28.54%52-week change7.98P/E (Trailing)‪96.43%‬Profit Margin
- BONSTASEBonus BioGroup Ltd.21.25BMarket Cap-34.07%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- BLRXTASEBioLineRx Ltd.4.17BMarket Cap-31.25%52-week change—P/E (Trailing)‪80.50%‬Profit Margin
- BOLTTASEBiolight Life Sciences Ltd.2.36BMarket Cap-102.41%52-week change-143.43P/E (Trailing)‪0.00%‬Profit Margin
- BIOVTASEBio View Ltd.1.16BMarket Cap-173.05%52-week change28.00P/E (Trailing)‪-76.92%‬Profit Margin
Profile Summary - EVGN - Evogene Ltd.
About
Evogene Ltd. is a biotechnology company that focuses on developing innovative solutions across various life science-based industries, including agriculture, pharmaceuticals, and industrial applications. By leveraging its unique computational predictive biology platform, Evogene aims to evolve new products through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
